Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 09, 2021

SELL
$30.19 - $45.49 $2.74 Million - $4.13 Million
-90,758 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$22.61 - $34.8 $2.05 Million - $3.16 Million
90,758 New
90,758 $3.16 Million

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $5.21B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Trustees Of Princeton University Portfolio

Follow Trustees Of Princeton University and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustees Of Princeton University, based on Form 13F filings with the SEC.

News

Stay updated on Trustees Of Princeton University with notifications on news.